Multi Medika (Indonesia) Today
| MMIX Stock | 96.00 6.00 5.88% |
PerformanceInsignificant
| Odds Of DistressLow
|
Multi Medika is selling for 96.00 as of the 25th of March 2025. This is a 5.88 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 89.0. Multi Medika has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. The performance scores are derived for the period starting the 25th of December 2024 and ending today, the 25th of March 2025. Click here to learn more.
Moving together with Multi Stock
Moving against Multi Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Multi Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Multi Medika's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Multi Medika or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Pharmaceutical Retailers, Healthcare (View all Sectors) |
Multi Medika Internasional (MMIX) is traded on Jakarta Exchange in Indonesia and employs 63 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 1.27 T. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Multi Medika's market, we take the total number of its shares issued and multiply it by Multi Medika's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Multi Medika Interna operates under Healthcare sector and is part of Pharmaceutical Retailers industry.
Check Multi Medika Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Multi Medika Internasional is USD1.27 Trillion. Multi Medika Internasional secures 7.0 % of its outstanding shares held by insiders and 0.0 % owned by institutional investors. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.
Check Multi Ownership Details
Multi Medika Interna Risk Profiles
Although Multi Medika's alpha and beta are two of the key measurements used to evaluate Multi Medika's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 7.3 | |||
| Semi Deviation | 7.43 | |||
| Standard Deviation | 11.13 | |||
| Variance | 123.99 |
Multi Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Multi Medika without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Forecasting Now
Equity ForecastingUse basic forecasting models to generate price predictions and determine price momentum |
| All Next | Launch Module |
Multi Medika Corporate Management
Elected by the shareholders, the Multi Medika's board of directors comprises two types of representatives: Multi Medika inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Multi. The board's role is to monitor Multi Medika's management team and ensure that shareholders' interests are well served. Multi Medika's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Multi Medika's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Eveline Susanto | CoFounder CFO | Profile | |
| Mengky Mangarek | Founder Director | Profile | |
| Karina Nurhadiah | Co Sec | Profile | |
| Christopher Lee | Chief Officer | Profile | |
| Jacky Raharja | Chief Officer | Profile |
Other Information on Investing in Multi Stock
Multi Medika financial ratios help investors to determine whether Multi Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Multi with respect to the benefits of owning Multi Medika security.